Abstract
There has been increased access to assisted reproductive technology (ART) treatment for transgender and gender diverse (TGD) patients. Yet, limited research has assessed fertility in patients who undergo gender affirming hormone therapy (GAHT). We evaluated the effect of testosterone (T) therapy in transgender males and ART treatment outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have